Ascelia Pharma AB (OSTO:ACE) Other Gross PPE : kr4.12 Mil (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Ascelia Pharma AB Other Gross PPE?

Ascelia Pharma AB's Other Gross PPE for the quarter that ended in Dec. 2024 was kr4.12 Mil.

Ascelia Pharma AB's quarterly Other Gross PPE declined from Jun. 2024 (kr0.59 Mil) to Sep. 2024 (kr0.36 Mil) but then increased from Sep. 2024 (kr0.36 Mil) to Dec. 2024 (kr4.12 Mil).

Ascelia Pharma AB's annual Other Gross PPE increased from Dec. 2022 (kr2.57 Mil) to Dec. 2023 (kr4.12 Mil) but then stayed the same from Dec. 2023 (kr4.12 Mil) to Dec. 2024 (kr4.12 Mil).

Ascelia Pharma AB Other Gross PPE Historical Data

The historical data trend for Ascelia Pharma AB's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascelia Pharma AB Other Gross PPE Chart

Ascelia Pharma AB Annual Data

Trend

Jun17

Jun18

Jun19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Gross PPE

Get a 7-Day Free Trial

2.53

2.57

4.12

Ascelia Pharma AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Gross PPE	Get a 7-Day Free Trial															4.12	0.83	0.59	0.36	4.12

Ascelia Pharma AB Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Ascelia Pharma AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascelia Pharma AB (OSTO:ACE) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

7ZA:Germany

Address

Hyllie Boulevard 34, Malmo, SWE, SE-215 32

Website

https://www.ascelia.com

Ascelia Pharma AB is an oncology-dedicated drug development company located in Malmo Sweden focused on orphan oncology It develops and commercializes novel drugs that address unmet medical needs and have a clear development and market pathway The company has two drug candidates Orviglance and Oncoral in clinical development.

Ascelia Pharma AB Headlines

No Headlines